Delivery Order SPE2DB20D6037-SPE2DB24FTUX5
- Not listed
- This firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $1,692.64 contract is for the delivery of dextroamphetamine-amphetamine 10 milligram tablets, with a performance period through April 15, 2024. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDV) with DLA valued up to $4,999,999 through 2025, under which this specific delivery order was...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $1,169.87 firm fixed-price delivery order is for the supply of 4,563,991,991 tablets of 10 mg dextroamphetamine-amphetamine, a common prescription medication. The contract is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This IDC allows...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $2,530.05 firm fixed-price contract is for the delivery of 4,558,698,205 dextroamphetamine-amphetamine 5 mg tablets to support the recurring medical supply needs of military health facilities. The contract has an ultimate completion date of October 7, 2022. DMS Pharmaceutical Group holds a $499,999,999 indefinite delivery...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $5,690.11 contract is for the delivery of 10 mg dextroamphetamine-amphetamine capsules, with a completion date of February 23, 2024. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, that allows the DLA to issue delivery...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at $1,360.58, is for the supply of Dextroamphetamine-Amphetamine 10 mg tablets to support the medical needs of military healthcare facilities. The contract is a firm fixed-price delivery order, with a performance period extending to February 6, 2025. DMS Pharmaceutical Group Inc. is a key supplier in the...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the supply of Dextroamphetamine-Amphetamine 15 mg capsules in 100-count packages. The total ceiling value of the contract is $3,022.29, with a period of performance through June 16, 2025. The contract does not have a set-aside designation. DMS Pharmaceutical Group Inc. has a significant...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,152.46 to DMS Pharmaceutical Group Inc. on September 15, 2025, for the supply of Dextroamphetamine-Amphetamine 30 mg capsules (100-count bottles). The delivery order, which carries a firm fixed-price contract type with an ultimate completion date of September 16, 2025, does not utilize any set-aside designation. Performance of this delivery order is based in Conshohocken, Pennsylvania. DMS Pharmaceutical Group Inc., a...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $2,526.78 award is for the delivery of 4,558,579,566 units of the prescription drug Dextroamphetamine-Amphetamine 20 mg Capsules. The delivery order was issued under DMS Pharmaceutical Group's $499,999,999 indefinite delivery contract (IDC) with the DLA, which allows the agency to place orders for a comprehensive...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Dextroamphetamine-Amphetamine 5 mg tablets, with a ceiling value of $1,244.88 and a performance period through April 23, 2025. This contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a $1,596.95 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 10 mg dextroamphetamine-amphetamine capsules, with a performance period through June 2025. This delivery order is placed under a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which...
- SPE2DB20D6037Indefinite Delivery Contract
- SPE2DB20D6037-SPE2DB24FTUX5Delivery Order
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $1,894.21 contract is for the supply of Dextroamphetamine-Amphetamine 5 mg tablets in 100-count bottles to support the medical supply needs of the Department of Defense (DoD). The contract is part of DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which has a ceiling value of up to $499,999,999 and runs through December 31, 2025. Through this IDC, DMS Pharmaceutical Group provides a wide range of pharmaceutical products, from common medications to specialized drugs and medical supplies, to fulfill the recurring medical needs of military health facilities worldwide. This contract does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 3/13/24 |